-
Jan 19, 2021, 01:00 AM
by
User Not Found
Bio-IT World | TRENDS FROM THE TRENCHES—Dan Stanzione has been working at the Texas Advanced Computing Center in Austin for three quarters of its 19-year tenure. Now the executive director and associate vice president of research, Stanzione runs TACC as both the research computing arm of the University of Texas as well as an independent National Science Foundation-funded supercomputing center. He sat down with Stan Gloss to talk about big compute, pandemics, and technology trends.
Full story
-
Jan 15, 2021, 17:42 PM
by
User Not Found
Bio-IT World | Oxford Nanopore Technologies and NVIDIA announced a collaboration this week to integrate the NVIDIA DGX Station A100 into Oxford Nanopore’s ultra-high throughput sequencing system, PromethION. Partnering the NVIDIA A100 Tensor Core GPU technology with the PromethION device aims to deliver the world’s most powerful sequencer that supports real-time analyses at scale and can also analyze any length fragment of DNA/RNA.
Full story
-
Jan 15, 2021, 11:48 AM
by
User Not Found
Bio-IT World | At the J.P. Morgan Healthcare Conference yesterday, PacBio’s new CEO, laid out a route to the clinic for PacBio’s HiFi sequencing reads, and set a 2021 goal of expansion across the business: improving commercial footprint, driving product development pipelines, and establishing market leadership in whole-genome clinical sequencing.
Full story
-
Jan 14, 2021, 18:13 PM
by
User Not Found
Bio-IT World I Single-dose nanoparticle vaccine triggers strong immune response in mice, mapping the unique structure of SARS-CoV-2 ORF8 protein, COVID-19 may eventually become as mild as common cold. Plus: Human lung bronchioalveolar tissue model successfully demonstrates viral replication along with potential therapy and mitochondria one of the first lines of defense.
Full story
-
Jan 14, 2021, 01:00 AM
by
User Not Found
Bio-IT World | Serge Saxonov, CEO and co-founder of 10x Genomics, painted a rosy picture of the future of single-cell technologies at the J.P. Morgan Healthcare Conference. And 10x has the product suite to enable that future, including a new version of the Chromium platform, a higher resolution version of the Visium platform, a coming In Situ platform, a wider rollout of the 10x Cloud, and new tools to address sample prep and cost.
Full story
-
Jan 13, 2021, 16:28 PM
by
User Not Found
Bio-IT World | Pacific Biosciences and Invitae today announced a multi-year collaboration to begin development of a production-scale high-throughput sequencing platform leveraging the power of PacBio’s highly accurate HiFi sequencing to expand Invitae’s whole genome testing capabilities.
Full story
-
Jan 13, 2021, 14:27 PM
by
User Not Found
Bio-IT World | As aging researchers are aware, “birthday candles are not a good guide” to either human health or longevity. But there is an abundance of clues in the genome and, as suggested by studies in animals, some of age-related damage is reversible by removing or reprogramming problematic cells or blocking the activity of key proteins.
Full story
-
Jan 11, 2021, 18:50 PM
by
User Not Found
Bio-IT World | At the 39th Annual J.P. Morgan Healthcare Conference in San Francisco today, Illumina CEO Francis deSouza outlined Illumina’s take on the genomics market, made partnership announcements, and launched Illumina Connected Analytics, an expanding software analytics platform. deSouza did not announce any new sequencing platforms, though he teased updates coming in 2021.
Full story
-
Jan 11, 2021, 14:35 PM
by
Full story
-
Jan 11, 2021, 14:35 PM
by
The EMA will use Panalgo’s Instant Health Data (IHD) platform to rapidly answer questions around drug safety and efficacy and better understand real-world medication use.
Full story
-
Jan 11, 2021, 13:27 PM
by
User Not Found
Bio-IT World | Kicking off news from the J.P. Morgan 39th Annual Healthcare Conference, Seqster announced the release of Seqster Platform v7.1 on the Microsoft Azure cloud this morning.
Full story
-
Jan 8, 2021, 01:00 AM
by
User Not Found
Bio-IT World I New hybrid approach identifies existing drugs that could be repurposed to treat SARS-CoV-2 and Cellid signs research contract with the International Vaccine Institute to expedite clinical development of “AdCLD-CoV-19” COVID-19 vaccine. Plus: Illumina and Helix will track the emergence and prevalence of new strains, including the highly transmissible B.1.1.7 variant.
Full story
-
Jan 7, 2021, 11:26 AM
by
Panthera’s clinical trial sites are helping to evaluate an alternative AstraZeneca vaccine for people who are unable to have the currently approved Covid-19 vaccines. The treatment is aimed at helping those people with a compromised immune system, who cannot be vaccinated, vaccine hesitant and those who are unlikely to respond to a vaccination.
Full story
-
Jan 7, 2021, 11:26 AM
by
Full story
-
Jan 7, 2021, 11:25 AM
by
ComputaBio, a US supplier of professional computational biology services, has launched molecular dynamics simulation services for industrial and academic customers to expedite the process of drug design.
Full story
-
Jan 7, 2021, 11:25 AM
by
Full story
-
Jan 7, 2021, 01:00 AM
by
User Not Found
Bio-IT World | When we spoke with the Bio-IT World vendor community, leaders reported working hard to synthesize what 2020 brought us and apply those learnings to 2021. As they each made predictions in their own business areas, some themes arose.
Full story
-
Jan 6, 2021, 18:36 PM
by
User Not Found
Bio-IT World | Charles River Laboratories acquired Distributed Bio on December 31, 2020. The acquisition marks the culmination of an exclusive partnership between these companies that was initiated in October 2018.
Full story
-
Jan 6, 2021, 01:00 AM
by
User Not Found
Bio-IT World | Scientists at RMIT University in Melbourne, Australia, have developed a nebulizer for delivering drugs and vaccines to the lungs by generating high-frequency sound waves on a microchip. Serendipitously, the device generates droplets “just the right size”—between 1 and 5 microns—for large molecules such as DNA and antibodies to reach the deep lungs.
Full story
-
Jan 4, 2021, 09:56 AM
by
User Not Found
Bio-IT World | Illumina and Harvard Pilgrim announce risk sharing for whole genome sequencing, new cryo-EM from Thermo Fisher, LSBio acquires Absolute Antibody, Presearch digitizes hand-written lab notes, and more.
Full story